From: PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression
Gene | Chrom | Number of ILC samples with mutation | Number of LCIS samples with mutation | Total |
---|---|---|---|---|
HSPG2 | 1 | 1 | 1 | 2 |
ROR1 | 1 | 1 | 1 | 2 |
SMG7 | 1 | 1 | 1 | 2 |
TSSC1 | 2 | 2 | 0 | 2 |
PIK3CA | 3 | 3 | 3 | 6 |
DOCK2 | 5 | 1 | 1 | 2 |
HAND1 | 5 | 2 | 0 | 2 |
UTP23 | 8 | 2 | 0 | 2 |
CACNB2 | 10 | 1 | 1 | 2 |
COX15 | 10 | 1 | 1 | 2 |
OR56B1 | 11 | 1 | 1 | 2 |
DDX11 | 12 | 1 | 1 | 2 |
PROSER1 | 13 | 1 | 1 | 2 |
TPTE2 | 13 | 1 | 1 | 2 |
PAK6 | 15 | 2 | 0 | 2 |
CDH1 | 16 | 3 | 3 | 6 |
PTRF | 17 | 1 | 1 | 2 |
ATP11C | X | 1 | 1 | 2 |
ATRX | X | 1 | 1 | 2 |